Sartorius Stedim Biotech (OTCMKTS:SDMHF) Trading Down 5% – Here’s What Happened

Sartorius Stedim Biotech S.A. (OTCMKTS:SDMHF) was down 5% during mid-day trading on Tuesday . The company traded as low as $193.54 and last traded at $193.54. Approximately 50 shares were traded during trading, a decline of 98% from the average daily volume of 2,588 shares. The stock had previously closed at $203.75.

Wall Street Analyst Weigh In

SDMHF has been the subject of a number of research reports. Barclays restated an “overweight” rating on shares of Sartorius Stedim Biotech in a research note on Tuesday, January 6th. The Goldman Sachs Group lowered Sartorius Stedim Biotech from a “buy” rating to a “neutral” rating in a research note on Monday, January 12th. One equities research analyst has rated the stock with a Buy rating and two have assigned a Hold rating to the company’s stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Hold”.

Sartorius Stedim Biotech Trading Down 5.0%

The stock has a fifty day simple moving average of $205.15 and a 200-day simple moving average of $224.53.

Sartorius Stedim Biotech Company Profile

Sartorius Stedim Biotech SA (OTCMKTS: SDMHF) is a global provider of bioprocessing equipment and services for the biopharmaceutical industry. The company develops and manufactures technologies that support the development and production of vaccines, monoclonal antibodies, therapeutic proteins and cell‐ and gene‐based therapies. Its solutions address both upstream processes—such as cell cultivation and fermentation—and downstream processes, including filtration, centrifugation and chromatography.

Key product offerings include single‐use bioreactors and mixers, modular filtration assemblies, prepacked chromatography columns, and a wide range of cell culture media and buffer systems.